Enteric fever caused by Salmonella enterica serotype Typhi (Salmonella Typhi) and Salmonella enterica serotype Paratyphi A, B or C (Salmonella Paratyphi A, B or C) remains a major disease burden in developing countries (Buckle et al., 2012) . Enteric fever is associated with poor sanitation and contaminated water and food; a faecal-oral transmissible disease. Salmonella Paratyphi is commonly reported throughout Asia (Arndt et al., 2014) . In sub-Saharan Africa, very few data exist on the prevalence and characterization of Salmonella Paratyphi. The lack of systematic surveillance data for Salmonella Paratyphi from sub-Saharan African countries makes it difficult to accurately estimate the proportion of enteric fever caused by Salmonella Paratyphi or accurately estimate the burden of disease (Arndt et al., 2014) . PubMed literature searches revealed that Nigeria reports the most comprehensive data on Salmonella Paratyphi from subSaharan Africa. Nigeria has reported that up to 34 % of enteric fever cases are caused by Salmonella Paratyphi A (Akinyemi et al., 2007) . Reports of Salmonella Paratyphi from other sub-Saharan African countries are very scanty; reports mostly just include the identification of Salmonella Paratyphi, with no further phenotypic or genotypic characterization of the isolates (Onyango et al., 2009; Tadesse, 2014) . Published South African data are equally lacking concerning the prevalence of Salmonella Paratyphi; we could only find a single report from 1978 on enteric fever caused by Salmonella Paratyphi C (Jacobs et al., 1978) . In the current study, we report on the phenotypic and genotypic characterization of Salmonella Paratyphi isolated in South Africa over the years 2003 to 2014. Bacterial isolates were investigated by the Centre for Enteric Diseases (CED) of the National Institute for Communicable Diseases, the national reference centre in South Africa for human infections due to enteric pathogens. Isolates were voluntarily submitted to the CED through a national active laboratory-based surveillance program from ,200 clinical microbiology laboratories across the country. In addition to this, the CED audits the national laboratory information system in order to identify additional cases that were not submitted for further characterization. Bacterial isolates were identified using standard phenotypic microbiological identification and serotyping techniques, briefly described as follows. As required, bacterial colonies were identified using the VITEK 2 Compact 15 automated microbial identification system (bioMérieux). Salmonella isolates were serotyped according to the White-Kauffmann-Le Minor Scheme. Differentiation of dtartrate-non-fermenting Salmonella Paratyphi B from d-tartrate-fermenting Salmonella Paratyphi B variant Java [variant L(+) tartrate(+)] was performed using a previously described PCR methodology which detects allelic variants of a gene associated with the fermentation of d-tartrate (Malorny et al., 2003) . Antimicrobial susceptibility testing was performed using the Etest method (bioMérieux); the following antimicrobials were tested: ampicillin, ceftriaxone, trimethoprim, sulfamethoxazole, chloramphenicol, ciprofloxacin, tetracycline and azithromycin. MIC breakpoint values as described by the Clinical Laboratory Standards Institute (CLSI, 2015) were used to define antimicrobial resistance. Genotypic relatedness of isolates was investigated by PFGE analysis of Xba I-digested genomic DNA on a CHEF-DR III electrophoresis system (Bio-Rad) using a PulseNet protocol (http://www. pulsenetinternational.org/protocols/). PFGE patterns were analysed using BioNumerics (version 6.5) software (Applied Maths). PFGE clusters were defined by isolates with patterns having $90 % similarity following dendrogram analysis.
To the best of our knowledge, this is the first study describing an investigation of paratyphoid fever in a sub-Saharan African country over an extended time period. In South Africa, for the years 2003 to 2014, .27 000 cases of Salmonella infection were recorded by the CED; 52 cases of Salmonella Paratyphi were identified as compared with 1122 cases of Salmonella Typhi. For the Salmonella Paratyphi cases, 51 were from human sources, whilst one case was sourced from food. Gender and age were known for 49 patients. With regard to gender, 53 % (26/49) were male and 47 % (23/49) were female. Age of patients ranged from 1 month to 70 years (median 26.5 years): 12 patients were ,5 years old, two patients were 5-14 years old and 35 patients were .14 years old. These age distributions were similar to those previously reported for cases of invasive non-typhoidal Salmonella in South Africa (Feasey et al., 2010) . The majority of cases (58 %; 30/52) were from two provinces in South Africa, i.e. Gauteng (35 %; 18/52) and Western Cape (23 %; 12/52).
For the 52 cases of Salmonella Paratyphi, 43 viable isolates were available for further analysis and further serotyped as Salmonella Paratyphi A (20/43; 47 %), Salmonella Paratyphi B (19/43; 44 %) and Salmonella Paratyphi C (4/43; 9 %) ( Table 1) . Of the 19 isolates identified as Salmonella Paratyphi B, 74 % (14/19) were found to be d-tartrate-fermenting Salmonella Paratyphi B variant Java [variant L(+) tartrate(+)]; a similar Salmonella Paratyphi B distribution was reported in a US study (Gupta et al., 2008) . For Salmonella Paratyphi A, most isolates (17/20; 85 %) were cultured from invasive specimens (blood cultures) as compared with the fewer (3/20; 15 %) non-invasive stool specimens. This was in contrast to Salmonella Paratyphi B, where most human isolates (17/18; 94 %) were cultured from stool specimens. This was not unexpected as most Salmonella Paratyphi B isolates were identified as variant Java, a variant known to typically cause a Salmonella gastroenteritis instead of bacteraemic enteric fever (Prager et al., 2003) .
In South Africa, the number of Salmonella Paratyphi isolates identified by the CED gradually increased over the period from 2003 to 2014 (Table 1) ; Salmonella Paratyphi A and Salmonella Paratyphi B variant Java were the most commonly identified. It was difficult to compare and contrast our data against data from other sub-Saharan African countries, as published data from other countries are limited. Overall, Salmonella Paratyphi accounted for a small proportion (52/1174; 4 %) of typhoidal Salmonella cases in South Africa, in contrast to Nigerian studies that reported that up to 34 % of typhoidal Salmonella cases are caused by Salmonella Paratyphi A (Akinyemi et al., 2007). Globally, the incidence of Salmonella Paratyphi infections (particularly Salmonella Paratyphi A) is increasing (Buckle et al., 2012) . In certain parts of Asia, Salmonella Paratyphi A has displaced Salmonella Typhi as the predominant (and sole) cause of enteric fever; the proportion of enteric fever cases caused by Salmonella Paratyphi A has reached 100, 65, 55 and 46 % for some regions of China, Nepal, India and Pakistan, respectively (Arndt et al., 2014). In some countries, this increasing proportion of Salmonella Paratyphi A has been ascribed to the successful vaccine interventions against Salmonella Typhi.
The prevalence of antimicrobial resistance amongst our viable human Salmonella Paratyphi isolates was: ampicillin (14 %), ceftriaxone (0 %), trimethoprim (2 %), sulfamethoxazole, (50 %), chloramphenicol (16 %), ciprofloxacin (50 %), tetracycline (17 %) and azithromycin (0 %). Our single food isolate (Salmonella Paratyphi B) was resistant to all antimicrobial agents, with the exception of susceptibility to chloramphenicol and azithromycin. With ciprofloxacin resistance at 50 % prevalence amongst our human isolates, this antimicrobial agent should be discouraged as a treatment option. Reduced susceptibility to ciprofloxacin has previously been reported amongst 18 % of Salmonella Paratyphi isolates from Nigeria (Akinyemi et al., 2007) . In most parts of Asia, ciprofloxacin resistance is commonplace amongst Salmonella Paratyphi; a study from Pakistan recently described prevalence rates as high as 84 % (Qamar et al., 2014) . Our isolates were all azithromycin-susceptible, based upon an MIC breakpoint value of $32 mg ml 21 for resistance; however, two isolates had a highly reduced susceptibility (MIC, 16 mg ml 21 ) to azithromycin, which was approaching the breakpoint for resistance. Azithromycin can be recommended as a first-line therapy for paratyphoid fever in South Africa. However, we must remain alert and mindful, as Salmonella Paratyphi A treatment failures with azithromycin have been reported with isolate MICs going as high as 64-256 mg ml 21 (Molloy et al., 2010) .
PFGE patterns were obtained for 42 isolates; they showed a large diversity of 28 different PFGE patterns (Fig. 1) , suggesting that PFGE analysis would be a fitting methodology for investigating outbreaks of paratyphoid fever in the African setting. For Salmonella Paratyphi A isolates, most (17/20) clustered together (cluster A; Fig. 1a) , with 11/20 isolates having an indistinguishable pattern (pattern 1; Fig. 1a ). Pattern 1 was compared against the PulseNet USA (http://www.cdc.gov/pulsenet/) database and found to be the most common Salmonella Paratyphi A pattern in the US database, with some isolates having evidence of patient travel history to India, Pakistan, Bangladesh, Cambodia and Vietnam (J. Concepció n-Acevedo, personal communication). For Salmonella Paratyphi B variant Java isolates, most (9/15) clustered together (cluster B; Fig. 1b) . Within this cluster, patterns 2 and 3 were compared against the PulseNet USA database. Patterns 2 and 3 were the second and twelfth most common Salmonella Paratyphi B patterns in the US database, respectively; there was no travel history information associated with these patterns (J. Concepció n-Acevedo, personal communication). Clustering of isolates is indicative of isolates with genetic similarity and clonality. Similar to our findings, other molecular investigations have also found that isolates of a particular paratyphoid serotype mostly cluster together. A study from Malaysia showed how PFGE analysis could clearly distinguish Salmonella Paratyphi B variant Java isolates from d-tartrate-non-fermenting Salmonella Paratyphi B isolates (Goh et al., 2003) . Using PFGE analysis, a study from China reported genetic similarity of Salmonella Paratyphi A isolates (Gu et al., 2015) .
In conclusion, Salmonella Paratyphi is rarely reported in South Africa. Within this group, Salmonella Paratyphi A and Salmonella Paratyphi B variant Java were the most commonly identified isolates. Azithromycin can be recommended as a first-line therapy for paratyphoid fever in South Africa. With no paratyphoid vaccines yet available, prevention and control of infection will rely on good sanitation and ensuring the safety of water and food supplies. 
